𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum p53 autoantibodies: incidence in ovarian carcinoma

✍ Scribed by K.A. Angelopoulou; M. Stratis; E.P. Diamandis

Book ID
103041950
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
121 KB
Volume
28
Category
Article
ISSN
0009-9120

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical significance of serum and ascit
Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma
✍ Burghard Abendstein; Christian Marth; Elisabeth MΓΌller-Holzner; Martin Widschwen πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## BACKGROUND. Accumulation of mutated p53 in malignant cells can lead to the generation of anti-p53 autoantibodies in the serum and other body fluids of cancer patients. This retrospective study was performed to evaluate the prognostic significance of preoperative serum and ascitic anti-p53 antibo

Serum copper in ovarian carcinoma
Serum copper in ovarian carcinoma
✍ Allan J. Jacobs; Gara M. Sommers; Janice H. Axelrod; Andrew E. Galakatos; Ming-S πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 256 KB πŸ‘ 2 views

The serum copper and CA 125 levels of 31 patients with epithelial ovarian carcinoma were determined. Serum copper was elevated in seven patients and CA 125 was elevated in 22 patients. A rise in serum CA 125 always was associated with disease progression. In comparison, serum copper fluctuation did

Chemosensitivity and p53-dependent apopt
Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma
✍ Shinya Sato; Junzo Kigawa; Yukihisa Minagawa; Makoto Okada; Muneaki Shimada; Mas πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 2 views

## BACKGROUND. Although p53 gene mutation frequently is observed in ovarian carcinoma, the function of the p53 gene in chemosensitivity has not been defined conclusively. The objective of the current study was to elucidate the relation between chemotherapy-induced apoptosis through the p53 pathway